67 Epizód

  1. #47 Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD

    Közzétéve: 2022. 04. 29.

  2. #46 How Is Translational Genomics Reducing Background Noise In Multi-Disease Detection? With Aiguo "Adam" Zhang

    Közzétéve: 2022. 04. 22.

  3. #45 Does company culture really affect drug development?

    Közzétéve: 2022. 04. 15.

  4. #44 Addressing One Of The World’s Biggest Drivers Of Disease: Inflammation With Jim Woody, M.D., Ph.D. - CEO 180 Life Sciences

    Közzétéve: 2022. 04. 01.

  5. #43 How to leverage past experience in developing treatments for rare disease. James Mackay, PhD - CEO, Aristea Therapeutics

    Közzétéve: 2022. 03. 25.

  6. #42 Regenerative Medicine? How two companies are attacking nerve damage.

    Közzétéve: 2022. 03. 12.

  7. #41 Is axonal transport the key to solving neurodegenerative diseases? Maria Maccechini, PhD - CEO, Annovis Bio

    Közzétéve: 2022. 03. 04.

  8. #40 Treatments that can reach beyond on the function of drugs? James Joyce, CEO - Sigyn Therapeutics

    Közzétéve: 2022. 02. 25.

  9. #39 How can digital health change the success of patient care? Waqaas Al-Siddiq, DBA, CEO - Biotricity

    Közzétéve: 2022. 02. 18.

  10. Bonus Episode! Digital Health Panel with Biotricity and DarioHealth

    Közzétéve: 2022. 02. 17.

  11. #37 How many lives would be changed with effective prevention of thromboembolic events? John Glasspool, CEO of Anthos Therapeutics

    Közzétéve: 2022. 02. 11.

  12. #36 Can Shoreline Biosciences change the future of cell therapy through pluripotent stem cells?

    Közzétéve: 2022. 02. 04.

  13. #35 Can Biomea Change the World with Irreversible Drugs and Covalent Bonds? Thomas Butler, CEO - Biomea Fusion

    Közzétéve: 2022. 01. 04.

  14. #33 Reducing friction at Clinical Trial Start-Up - Sam Searcy, CEO of CliniStart

    Közzétéve: 2021. 12. 18.

  15. #32 People, the most valuable asset a business has. Brenda Sousa - Chief HR Officer

    Közzétéve: 2021. 12. 13.

  16. #31 Managing CRO relationships and unique business models - Stewart Hallet - COO SFJ Pharmaceuticals

    Közzétéve: 2021. 11. 24.

  17. #30 Brazen Bio Part II - Live and In Person!

    Közzétéve: 2021. 11. 04.

  18. #29 Why do we resist? Applying clinical psychology to clinical trials. Kathleen Starr, PhD - EVP Behavioral Insights, Syneos Health

    Közzétéve: 2021. 10. 29.

  19. #28 Vaccine Durability, Diversified Pipeline, Winning Strategy - Seth Lederman, MD - CEO Tonix Pharmaceuticals

    Közzétéve: 2021. 10. 01.

  20. #27 How do you effectively manage the CMC process? With Doug Looker, PhD

    Közzétéve: 2021. 09. 21.

2 / 4

Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!

Visit the podcast's native language site